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Papain is an enzyme used in topical formulations as a proteolytic debriding agent for the treatment of 
open, extensive wounds and burnings. It is also employed as an enhancer for cutaneous permeation of 
active compounds, chemical peeling and as a progressive depilatory agent. The stability of formulations 
containing enzymes is not easy. In this research, papain was modified with polyethylene glycol in order 
to increase the stability of the formulations. The comparative Normal Stability Testing of the topical 
formulations containing unmodified and modified papain showed that the modified variety presented 
with a differentiated profile under the adopted temperature conditions (5.0 ± 1.0 °C; 22.0 ± 2.0 °C; 
40.0 ± 2.0 °C). The most suitable condition for non-modified papain were 5.0 ± 1.0 °C and, for modified 
papain, they were 22.0 ± 2.0 °C. These results confirmed the higher stability of modified papain compared 
to free papain, as well as its potential to be applied in topical formulations.
Uniterms: Papain/use in topical formulations. Papain/normal stability test. Poliethylene glycol/use. 
Topical formulations/development. Papain/enzimatic activity. 
A papaína é uma enzima utilizada em formulações tópicas como agente proteolítico debridante no 
tratamento de lesões abertas de grande extensão e queimaduras. É, também, empregada na pele íntegra 
como agente promotor da permeação cutânea de princípios ativos, peeling químico e como agente 
depilatório progressivo. A estabilidade de formulações contendo enzimas não é facilmente alcançada. No 
presente trabalho realizou-se a modificação da enzima com polietilenoglicol, visando maior estabilidade 
das formulações. A realização do Teste Estabilidade Normal comparativo entre as formulações contendo 
as formas da enzima não modificada e modificada demonstrou que a última apresentou um perfil de 
estabilidade diferenciado, nas diferentes condições (5,0 ± 1,0 °C; 22,0 ± 2,0 °C; 40,0 ± 2,0 °C). A condição 
de 5,0 ± 1,0 °C foi a mais adequada para a formulação contendo papaína não modificada enquanto a 
22,0 ± 2,0 °C foi indicada para aquela contendo a forma modificada. Estes resultados confirmaram o 
aumento da estabilidade da papaína modificada comparada com a livre e seu potencial de aplicação em 
formulações de uso tópico.
Unitermos: Papaina/uso em formulaçãoes tópicas. Papaina/teste de estabilidade. Polietilenoglicol/uso. 
Formulações tópicas/desenvolvimento. Papaina/atividade enzimática. 
INTRODUCTION
The use of enzymes in cosmetic formulations has 
been widely disseminated in the last years. Proteolytic 
enzymes, such as papain and bromelain, have been ap-
plied in Cosmetology for chemical peeling, depilatory 
preparations and as penetration enhancers (Lopes et al., 
2003; Traversa et al., 2003).
The action of papain on the skin has been investi-
gated by many researchers, who found positive results 
regarding hydration, penetration enhancement of active 
compounds and a decrease in hair growth velocity (El-
Kadi et al., 2001; Sim et al., 2003; Lopes et al., 2008; 
Traversa et al., 2003).
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Papain is an enzyme originated from the latex of 
the adult green papaya leaves and fruit, Carica papaya 
Linn. It is a mixture of proteins that contains a combina-
tion of papain and chymopapain (proteolytic enzymes that 
hydrolyse polypeptides), starch and esters, especially in 
bondings involving alkaline amino acids, leucine or gly-
cine, producing peptides with low molecular weight. The 
term refers not only to the dry rough latex, but also to the 
crystalline enzyme. Papaya trees are cultivated on most 
tropical countries (Merck Index, 2006; Martindale, 2009).
One of the limiting factors for the use of papain in top-
ical formulations is its low chemical stability. The enzymatic 
activity of papain may be influenced by environmental 
conditions such as temperature, light, oxygen, humidity and 
packing. The enzyme is more stable and active in pH 5.0-7.0 
(Sasmito, Demeester, Bracke, 1982; Sim et al., 2000). The 
stability of the enzyme (both as a solid and incorporated in 
semi-solid formulations) has been investigated at different 
temperatures and results have confirmed the decrease in 
its activity with the temperature increase (Arnon, 1970; 
Traversa et al., 2003; Szabó et al., 2006).
Kang & Warner (1974) researched the effect of pH 
on the activity of papain. The combined actions of pH and 
temperature on the stability of this enzyme have suggested 
a slight reduction at pH 5.0; some loss at 7.0 and significant 
reduction at pH 9.0, especially at 70 °C.
An alternative to increase papain stability involves 
modifying enzyme structure in order to protect its active 
hydrolysis site. There are many methods to modify the sta-
bility of enzymes, considering their specific action. There 
have been many attempts to stabilize papain  structure, 
such as: covalent bondings, interaction with immobilized 
ion metal, insolubilization in glutaraldehyde, imobilization 
in agarose, biopolymer, covalent bondings with polyether 
sulphone, coupling with polymeric sucrose, modification 
with succinic anhydride, simple absorption in Celite®, 
ionic absorption in CM-cellulose (cationic ion-exchange 
resin) and QAE-Sephadex® (anionic ion-exchange resin), 
and cross-linked covalent bonding (Sim et al., 2000; Afaq, 
Iqbal, 2001; Li et al. 2010).
Modifications in enzyme structure may lead to altera-
tions when it is added to pharmaceutical or cosmetic formu-
lations. The behavior of free papain in topical formulations 
is reported in the literature. Velasco et al. (1999) have stud-
ied the stability of papain incorporated in gel formulations 
at different temperatures and they found that the formulation 
presented higher stability when kept under refrigeration. Ac-
cording to the Stability Test, the enzyme kept approximately 
70% of its initial activity for nearly two months.
The stability study supplies information concerning 
product behavior during a given period of time and under 
the environmental conditions it may undergo. Therefore, 
Preliminary and Accelerated Stability Tests are performed 
at different temperatures, relative humidity and lighting 
conditions that accelerate the degradation of formulations. 
These tests supply information to select the best prepara-
tion to undergo the Normal Stability Test for 90-120 days 
at the following temperatures: environmental temperature 
(20.0 to 25.0 ± 2.0 °C), high temperatures (37.0; 40.0; 45.0 
and 50.0 ± 2.0 °C), and low temperatures (-5.0; 5.0 and 
10.0 ± 2.0 °C) (Baby et al., 2004; Brasil, 2004)
Some parameters evaluated in the Stability Tests 
of formulations for topical use, in general, include: or-
ganoleptical characteristics (aspect, color, odour, taste), 
uniformity, pH, viscosity, conductivity, microbiological 
contamination, rupture point, saponification index, al-
coholic content, active principle content, among others 
(Baby et al., 2004; Brasil, 2004).
A comparative study between the free and modified 
enzymes has aimed to apply the latter as raw material in 
cosmetic and pharmaceutical formulations (Traversa et al., 
2003; Sim et al., 2003; Pieper, Caliri, 2003).
The aim of this research is to assess the physical, 
physicochemical and chemical stability of free and modi-
fied papain incorporated in cosmetic formulations – gels 
(reference preparation) and emulsions – in order to enable 
the industry-scale production of formulations in a stable 
manner that makes them viable for commercialization.
MATERIAL AND METHODS
Stability test
We developed seventeen O/W emulsions containing 
0.8 % (w/w) papain (obtained from Wallerstein, Brazil) 
(Traversa et al., 2007). They were composed of: emul-
sifying wax NF (purchased from Chemyunion - Brazil); 
paraffinum liquidum (purchased from Mapric - Brazil); 
myristyl lactate and isopropyl palmitate (gifts from Croda, 
Brazil); ethylparaben, isobutylparben, methylparaben, 
propylparaben (and) phenoxyethanol; decyl oleate and 
hydroxylated milk glycerides (gift from Ionquímica, Bra-
zil); dibutyl adipate (gift from Cognis, Brazil); ammonium 
acryloyldimethyltaurate/VP copolymer (gift from Clariant, 
Brazil); carbomer and acrylates/C10-30 alkyl acrylate 
crosspolymer (purchased from Noveon Consumer Special-
ties Lubrizol, Brazil); hydroxyethylcellulose (purchased 
from Galena, Brazil); propylene glycol (purchased from 
Cosmotec, Brazil); and cyclopentasiloxane (gift from Dow 
Corning - Brazil). The quantitative composition (% w/w) 
of the formulations is described on Tables I and II. 
The formulations were evaluated 24 hours after their 
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TABLE I – Qualitative and quantitative composition of the formulations containing 0.8% of papain, prepared for macroscopic 
evaluation and sensorial aspect (1 to 7)
COMPONENTS (INCI Name *) % (w/w)
1 2 3 4 5 6 7
Oil phase
Emulsifying Wax NF 1.5 1.5 1.5 1.5 1.5 1.5 1.5
Paraffinum Liquidum 0.5 0.5 0.5 0.5 0.5 0.5 0.5
Myristyl Lactate 1.0 1.0 1.0 1.0 1.0 1.0 1.0
Isopropyl Palmitate 2.0 2.0 2.0 2.0 2.0 2.0 2.0
Decyl Oleate 2.0 2.0 2.0 2.0 2.0 2.0 2.0
Hydroxylated Milk Glycerides 0.5 0.5 0.5 0.5 0.5 0.5 0.5
Dibutyl Adipate 1.0 1.0 1.0 1.0 1.0 1.0 1.0
Ammonium Acryloyldimethyltaurate/VP copolymer 1.0 1.5 - - - - -
Aqueous phase
Carbomer - - 1.0 1.5 - - -
Acrylates/C10-30 alkyl acrylate crosspolymer - - - - 1.0 0.25 0.5
Hydroxyethylcellulose - - - - - - -
Propylene glycol 2.5 2.5 2.5 2.5 2.5 2.5 2.5
Water q.s.p. 100.0 100.0 100.0 100.0 100.0 100.0 100.0
Additional phase
Ethylparaben; isobutylparaben; methylparaben; 
phenoxyethanol; propylparaben
0.5 0.5 0.5 0.5 0.5 0.5 0.5
Cyclopentasiloxane 2.5 2.5 2.5 2.5 2.5 2.5 2.5
Essence 0.5 0.5 0.5 0.5 0.5 0.5 0.5
(-) No added components, (*) INCI Name (International Nomenclature of Cosmetic Ingredient, INDEX ABC, 2009)
preparation. The macroscopically stable ones were sub-
mitted to the Preliminary Stability Test, which consisted 
of centrifugation and thermal stress tests. Organoleptical 
characteristics (aspect, color and odor) and pH were evalu-
ated at the beginning and at the end of each test, at room 
temperature (Roland et al., 2003; Brasil, 2004).
The formulations without important alterations un-
derwent the Accelerated Stability Test, and were submitted 
to the same conditions and evaluation periods described in 
the literature 24 hours after preparation and incorporation 
of papain and cysteine. Organoleptical characteristics, pH, 
apparent viscosity and conductivity values were noted 
(Brasil, 2004; Baby et al., 2004).
After the Accelerated Stability Test, two formula-
tions were selected for the Normal Stability Test (Table 
III). These were submitted to the same evaluation condi-
tions and periods described in the literature 24 hours after 
their preparation under the abovementioned conditions. 
Organoleptic characteristics, pH variation, apparent vis-
cosity, conductivity and papain activity were evaluated 
(Brasil, 2004; Baby et al., 2004).
Enzyme modification
The polyethylene glycol (PEG) used for the pe-
gylation of the enzyme was modified with succinyl anhy-
dride and activated with 1-hydroxypyrrolidine-2,5-dione 
(NHS) and N,N’-dicyclohexylcarbodiimide (DCC), form-
ing the methoxypolythylene glycol succinimidylsuccinate 
(SS-PEG) shown in Scheme 1. This derivative reacts 
preferably with the free amines of the enzyme lysine side 
chain. The reaction of SS-PEG with papain was performed 
in pH 7.5 buffer at 15.0 °C for a period of 12 hours, under 
magnetic stirring in a glass reactor (Scheme 2). Papain 
concentration was 5% (w/v) (Holtsberg et al., 2002; Mat-
suyama et al., 1991).
As a control for the incorporation of the polyethyl-
ene glycol in papain, analysis of poliacrylamide gel elec-
trophoresis and dosage of the polyethylene glycol group 
incorporated in the papain structure were performed by 
spectrophotometry with trimethyl benzene sulphonic acid 
(TNBS) (Habeeb, 1966).
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Papain activity - method validation
Benzyloxycarbonyl-phenylalanyl-arginine 7-amido-
4-methylcoumarin was used as substrate in the assay that 
was performed in microplates. The production of 7-amido-
4-methylcoumarin (7-MCA) over different periods of 
time was used to quantify the concentration of papain in 
pharmaceutical forms (gel and emulsion). This method 
presented a linear relationship between papain concentra-
tion and rate of 7-MCA production (R = 0.9974). It also 
presented an estimated limit of detection (LOD) of 0.040 
USP mL–1; an estimated limit of quantification (LOQ) of 
0.12 USP.mL–1; a precision (RSD %) ranging from 2.7 to 
5.0 and an accuracy (E%) ranging from 95.3 to 96.7. The 
components of the topical formulation did not interfere in 
papain detection (Kanaoka, Takahashi, 1977; Brasil, 2003; 
Pinto et al., 2007).
RESULTS AND DISCUSSION
Preliminary tests
The preliminary tests enabled the identification of 
signs of instability in six of the formulations submitted to 
the thermal stress and centrifugation tests, such as phase 
separation, formation of lumps and changes in odour. Four 
formulations were approved and subsequently submitted 
to the Accelerated Stability Test.
The results obtained indicated that the formulation 
containing polymer Acrylates/C10-30 Alkyl Acrylate 
Crosspolymer did not remain stable after the preliminary 
tests, probably because the preparations require differ-
ent elaboration techniques concerning stirring speed and 
dispersion time.
The behavior of an emulsion submitted to cen-
TABLE II – Qualitative and quantitative composition of the pre-formulations containing 0.8% of papain, prepared for macroscopic 
evaluation and sensorial aspect (8 to 17)
COMPONENTS (INCI Name*) % (w/w)
8 9 10 11 12 13 14 15 16 17
Oil Phase
Emulsifying Wax NF 1.5 1.5 1.5 1.5 1.5 1.5 1.5 1.5 1.5 3.0
Paraffinum Liquidum 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5
Myristyl Lactate 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0
Isopropyl Palmitate 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0
Decyl Oleate 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0
Hydroxylated Milk Glycerides 0.5 0.5 0.5 0.5 0.5 2.0 2.0 2.0 2.0 2.0
Dibutyl Adipate 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0
Ammonium Acryloyldimethyltaurate/VP 
copolymer
- 0.5 1.0 2.0 - - - - - -
Aqueous phase
Carbomer - - - - 0.5 - - - - -
Acrylates/C10-30 alkyl acrylate 
crosspolymer
1.5 - - - - 0.5 0.25 - - -
Hydroxyethylcellulose - 0.5 0.5 0.5 0.5 0.5 0.5 0.5 1.0 -
Propylene glycol 2.5 2.5 2.5 2.5 2.5 2.5 2.5 2.5 2.5 2.5





0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5
Cyclopentasiloxane 2.5 2.5 2.5 2.5 2.5 2.5 2.5 2.5 2.5 2.5
Essence 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5
(-) No added components, (*) INCI Name (International Nomenclature of Cosmetic Ingredient, INDEX ABC, 2009)
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TABLE III – Formulations submitted to the Normal Stability Test. Gel (reference), preparations 2 and 3 [0.8% (w/w) of non-modified 
papain and 0.16% (w/w) of cysteine], and preparation 2M with 22.06% (w/v) of modified papain and 0.16% (w/w) of cysteine 
Formulation
Components (INCI Name*) Gel 2 3 2M
% w/w
Oil Phase
Emulsifying Wax NF - 1.5 1.5 1.5
Paraffinum Liquidum - 0.5 0.5 0.5
Myristyl Lactate - 1.0 1.0 1.0
Isopropyl Palmitate - 2.0 2.0 2.0
Decyl Oleate - 2.0 2.0 2.0
Hydroxylated Milk Glycerides - 0.5 0.5 0.5
Dibutyl Adipate - 1.0 1.0 1.0
Ammonium Acryloyldimethyltaurate/VP copolymer - 1.5 - 1.5
Aqueous phase
Carbomer 0.6 - 1.0 -
Propylene glycol 5.0 2.5 2.5 2.5
Water q.s.p. 100 100 100 100
Additional Phase
Methylparaben 0.3 0.3 0.3 0.3
Ethylparaben; isobutylparaben; methylparaben; phenoxyethanol; propylparaben  - 0.5 0.5 0.5
Cyclopentasiloxane - 2.5 2.5 2.5
Essence - 0.5 0.5 0.5
Free papain 0.8 0.8 0.8 -
Modified papain - - - 22.06
L-cysteine HCl monohydrate 0.16 0.16 0.16 0.16
(-) No added components, (*) INCI Name (International Nomenclature of Cosmetic Ingredient, INDEX ABC, 2009)
trifugation depends on the difference in densities of the 
oil and aqueous phases and also on the interfacial resis-
tance between the phases. Thermal stress accelerates the 
degradation process of components in the preparations. 
After centrifugation, the formulation without thickening, 
emulsifying or film-forming agents did not withstand the 
test conditions. This result was expected, because the 
concentration of the self-emulsifying component was in-
ferior to that recommended by the manufacturer (2.0 %). 
The formulation that contained only a cellulose derivative 
(hydroxyethylcellulose) also did not withstand the test, 
what is in accordance with the experiments performed by 
Velasco et al. (1999) and Traversa et al. (2003), in which 
the gel prepared with a cellulose derivative presented 
lower stability than that of the gel prepared with carbomer 
(Velasco et al., 1999; Roland et al., 2003; Traversa et al., 
2003).
The formulations that did not present signs of insta-
bility after the Preliminary Test were the ones with poly-
mers ammonium acryloyldimethyltaurate/VP copolymer 
(formulations 2 and 10, as shown in Tables I and II) and 
carbomer (formulations 3 and 12, as shown in Tables I 
and II). These presented only with odour modifications 
after the thermal stress test, due to enzyme degradation 
at high temperatures, causing the subsequent release of a 
characteristic sulfur odour (Tables I and II). The polymers 
may have increased the emulsion stability because they 
reduced the phase separation speed.
Accelerated stability test
This Test allowed us to choose the most stable 
preparations under the different environmental condi-
tions. Formulations 10 and 12 (Table II) contained not 
only the polymers ammonium acryloyldimethyltaurate/VP 
copolymer and carbomer but also hydroxyethylcellulose, 
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SCHEME 1 - Obtention of the PEG activated derivative, used to modify the papain.
SCHEME 2 - Peglylation of  papain.
and presented the highest variations in organoleptical 
characteristics, pH, apparent viscosity and conductivity.
These results show that the formulations (2 and 3) 
with only one of the previously mentioned synthetic poly-
mers tended to have a better performance when compared 
to the ones containing a cellulose derivative. Formulations 
2 and 10 (Tables I and II) presented the most altered pH 
values, with a maximum of 0.6 units under conditions of 
45.0 ± 2.0 /-10.0 ± 1.0 °C (laboratory oven/freeze cycle). 
This behavior was expected, due to the drastic condi-
tions for formulations containing enzymes. Despite the 
variations, pH values were suitable for enzymatic activity 
(Velasco et al., 1999; Merck Index, 2006).
There was a variation in apparent viscosity at 
45.0 ± 2.0 °C with a 40% and 35% decrease for formulations 
12 and 10, respectively. This result was also expected because 
of enzyme degradation under high temperatures, which may 
interfere in formulation viscosity. The concentrations of 
ammonium acryloyldimethyltaurate/VP copolymer (1.0% 
w/w) and carbomer (0.5% w/w) in these preparations were 
not enough to maintain their viscosity profiles, and neither 
was the presence of hydroxyethylcellulose. Traversa et al. 
(2003) also observed the instability of preparations with pa-
pain in the presence of hydroxyethylcellulose. They prepared 
a papain gel (0.8% w/w) which underwent the centrifugation 
test (Preliminary Stability Test), which led to the formation 
of crystals and enzyme decantation. 
There was also a variation in conductivity. The highest 
difference appeared under the conditions of -10.0 ± 1.0 °C 
(freezer), with a tendency for augmentation in all formula-
tions. The highest variation (40%) was founf for formula-
tion 10, whilst the other formulations presented variations 
below 25%. Electric conductivity is important to monitor 
the stability of O/W emulsions and to verify the integrity 
of the external phase, mainly for emulsions that are stored 
for long periods of time. Results showed that formulation 
10 did not present external phase integrity when exposed 
to -10.0 ± 1.0 °C (freezer), which is considered as a drastic 
condition (Griffin et al., 1967; Latreille, Paquin, 1990).
Due to the results of the Accelerated Stability Test, 
formulations 2 and 3 were selected for the Normal Stability 
Test.
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Normal stability test
The formulations evaluated (24 hours after the 
preparation, for stabilization) during the Normal Stability 
Test were:
• 2 with papain;
• 3 with papain;
• 2M, (same as formulation 2) with modified papain;
• papain gel (reference formulation, stored under 
refrigeration conditions (5.0 ± 1.0 ° C)).
Figure 1 shows the variation in papain activity dur-
ing the Normal Stability Test at 5.0 ± 1.0 °C.
According to Figure 1, at 5.0 ± 1.0 °C (refrigerator), 
the papain gel (reference sample) had a slower initial de-
crease in enzymatic activity than the emulsions containing 
ammonium acryloyldimethyltaurate/VP copolymer and 
carbomer (formulations 2 and 3, respectively) until the 30th 
day, and maintained 70% of remaining activity. This result 
may have occurred because of the presence of Emulsifying 
Wax NF (non-ionic emulsifier) in the two last prepara-
tions, which may have interacted with the enzyme, thus 
reducing its stability. As to the gel, the vehicle is simpler 
and includes a polymeric gelifying agent that stabilizes 
the enzyme. After this time, all formulations (2, 3 and 
Gel) behaved similarly, with similar differences in activ-
ity (%). After 90 days, all formulations obtained values 
of approximately 70%. The same behavior was observed 
by Velasco et al. (1999), who studied papain incorporated 
into gel formulations. They have stated that the preparation 
with carbomer retained approximately 70% of the initial 
activity after 57 days at 5.0 ± 1.0 °C (refrigerator).
Figure 2 represents the variation in papain activity 
during the Normal Stability Test at 22 ± 2.0 °C.
FIGURE 1 – Papain activity variation (%) for formulations 2, 
3, 2M and Gel, under the conditions of 5.0 ± 1.0° C, during the 
Normal Stability Test.
Formulations 2 and 3 presented different decreas-
ing profiles when exposed to temperatures of 22.0 ± 2.0 
°C (Figure 2). Formulation 3 was found to have a papain 
activity decrease of almost 50% at the 7th day and 80% at 
the 90th day. Formulation 2 was found to have papain activ-
ity reduced by 50% at the 30th day and by approximately 
60% at the 90th day.
Figure 3 shows the variation in papain activity dur-
ing the Normal Stability Test at 40 ± 2.0 °C.
Formulation 3 presented approximately half of the 
remaining activity value at 40.0 ± 2.0 °C, when compared 
to formulation 2  (Figure 3) until the 30th day. After this 
period, the profile became similar. After 60 days, both 
formulations possessed papain activity inferior to 10% in 
relation to the initial value. This was maintained until the 
end of the test. These results were already expected, as the 
increase in temperature accelerated the process of enzyme 
decomposition (Rajalakshmi, Sundaram, 1995).
The activity of the enzyme incorporated in formula-
tions 2, 3 and gel was affected by the temperature increase 
FIGURE 2 – Papain activity variation (%) for formulations 2, 
3, 2M and Gel at 22 ± 2.0 °C during the Normal Stability Test.
FIGURE 3 - Papain activity variation (%) for formulations 2, 
3, 2M and Gel at 40 ± 2.0 °C during the Normal Stability Test.
C. A. S. Oliveira Pinto, P. S. Lopes, F. D. Sarruf, B. Polakiewicz, T. M. Kaneko, A. R. Baby, M. V. R. Velasco758
during the Normal Stability Test. After 90 days, the results 
were: (1) 40.0 ± 2.0 °C - the remaining activity for for-
mulations 2 and 3 was inferior to 10 %; (2) 22.0 ± 2.0 °C 
- data obtained were 47% and 23%, respectively; 
(3) 5.0 ± 1.0 °C - all formulations (2, 3 and Gel) presented 
with a remaining activity of approximately 70%. The 
preparations presented minimum activity loss under the 
last temperature value, which concurs with the literature 
(Velasco et al., 1999; Rajalakshmi, Sundaram, 1995). 
The modified enzyme presented an increase in 
enzymatic activity over the course of time for all studied 
conditions. After papain pegylation and subsequent enzy-
matic activity analysis, we noticed a decrease to 44% when 
compared to the unmodified enzyme. This difference was 
taken into account when the modified enzyme was incor-
porated in the formulation. Due to the results obtained for 
the Normal Stability Test, it was verified that the enzyme 
presented some enzymatic activity loss but this loss may 
not have been definitive. 
In the Normal Stability Test, at 40.0 ± 2.0 °C (Fig-
ure 3), there was an activity of 200% on the 15th day 
comparing to the initial value with a further decrease to 
133% on the 90th day. At 22.0 ± 2.0 °C (Figure 2), this 
value was obtained after 30 days and kept until the 90th. 
At 5.0 ± 1.0 °C (Figure 1), this value was only reached 
after 90 days. This behavior could be explained because 
the modified enzyme is unavailable to exert its action at the 
beginning, and, as time decurred and temperature acted, 
the enzymatic activity of papain pegylated was changed. 
This behavior was similar to the one found by 
Rajalakshmi & Sundaram (1995). They modified papain 
with polymeric sucrose and observed the enzyme when 
exposed to a 8M urea solution at 37 °C for 24 hours. 
These conditions were critical for papain due to the high 
temperature and to the presence of the urea solution, acting 
as an inhibitive agent. In this research it could be observed 
that, during a 4-hour period, enzyme activity increased 
by 170% compared to the initial activity (Rajalakshmi, 
Sundaram, 1995).
Miyamoto et al. (2004) have stabilized and conju-
gated papain with hydrosoluble phospholipidic polymeric 
chains containing a reactive terminal group. The enzyme 
was kept at 25 ºC for activity analysis. Enzymatic activ-
ity was found to have increased, and it reached 150% of 
the initial value after 28 days. This phenomenon was ex-
plained by the formation of conjugate papain aggregates 
that are released over the course of time.
The objective of the preparation with modified 
enzyme was to elevate enzyme stability and to promote 
its gradual liberation in the action site, thus enhancing its 
therapeutical/cosmetic efficacy.
Among the temperatures of the Normal Stability 
Test, the most stable for the formulation with modified 
papain was 22.0 ± 2.0 °C (Figure 2), at which an activity 
increase was observed until the 30th day, with further sta-
bilization. Under the refrigerator conditions (5.0 ± 1.0 °C), 
the enzyme did not present a stabilization profile until the 
90th day. At 40.0 ± 2.0 °C, there was a variation in enzy-
matic activity, with a fast increase in the first 15 days and 
a subsequent lack of stabilization in the activity profile. 
It was noticed that 22.0 ± 2.0 °C was the most suitable 
condition for modified papain. This highlights the advan-
tage of modified papain, when compared to its free form, 
which requires refrigerator conditions (5.0 ± 1.0 °C) for 
suitable storage.
Formulations 2 and 2M possessed the lowest 
variations concerning pH (approximately 15% at 
–40.0 ± 2.0 °C), as temperature increase degrades the 
enzyme and alters pH values. Under the other conditions, 
pH variations were inferior to 7.0%, but the values were 
considered suitable for papain enzymatic activity (5.0 to 
7.0) (Velasco et al., 1999; Merck Index, 2006). 
As to the viscosity variation for formulation 2 under 
all conditions, no oscillation exceeded 20% in relation to 
the initial conditions, with a tendency to increase. The poly-
meric emulsifying agent in this preparation was Ammonium 
Acryloyldimethyltaurate/VP copolymer. There might have 
been an interaction between this polymer and the other for-
mulation components, in addition to its degradation by pa-
pain. However, this oscillation did not significantly alter the 
organoleptical characteristics. Despite the variation around 
17% for formulation 3 at 40.0 ± 2.0 °C, the results were 
satisfactory at 5.0 ± 1.0 °C and 22 ± 2.0 °C, with variations 
below 10%. Formulation 2 varied less than 10% under all 
conditions. These results indicate the stability of emulsions, 
concerning the external phase. The likely explanation would 
be that the polymers maintained their structures during the 
study, thus avoiding separation of phases (Griffin et al., 
1967; Latreille, Paquin, 1990).
CONCLUSION
Amongst the formulations with 0.8% (w/w) non-
modified papain, the emulsion containing carbomer pre-
sented the most suitable pH, viscosity and conductivity 
responses under all temperature conditions (5.0 ± 1.0 °C; 
22.0 ± 2.0 °C, 40.0 ± 2.0 °C), when compared to the emul-
sion containing the polymer ammonium acryloyldimeth-
yltaurate/VP copolymer.
The activity of the non-modified enzyme during the 
Normal Stability Test incorporated into the formulations 
that were kept at 22.0 ± 2.0 °C was influenced by the type 
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of polymer. The emulsion containing ammonium acry-
loyldimethyltaurate/VP copolymer maintained approxi-
mately two times the enzymatic activity, when compared 
to the formulation containing carbomer. For the other 
temperatures, the different polymers did not influence 
enzyme activity.
Temperature influenced the behavior of non-modi-
fied papain activity in the emulsions. At 40.0 ± 2.0 °C there 
was a faster decrease in enzymatic activity, in the order of 
approximately 90% in 90 days. 
The storage of the formulations in the refrigera-
tor (5.0 ± 1.0 °C) was found to be the best condition for 
emulsions containing 0.8% (w/w) of non-modified papain, 
ammonium acryloyldimethyltaurate/VP copolymer and 
carbomer.
The method of papain modification with polyeth-
ylene glycol altered the release profile and the activity 
of the enzyme incorporated into the emulsion containing 
ammonium acryloyldimethyltaurate/VP copolymer, under 
all conditions assessed. Enzyme stability was higher than 
in the formulations containing the non-modified enzyme.
The temperature of 22.0 ± 2.0 °C was the most 
suitable for the emulsion containing modified papain 
and the polymer ammonium acryloyldimethyltaurate/VP 
copolymer.
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